144 related articles for article (PubMed ID: 25454926)
1. Novel overgrowth syndrome phenotype due to recurrent de novo PDGFRB mutation.
Takenouchi T; Yamaguchi Y; Tanikawa A; Kosaki R; Okano H; Kosaki K
J Pediatr; 2015 Feb; 166(2):483-6. PubMed ID: 25454926
[TBL] [Abstract][Full Text] [Related]
2. Kosaki overgrowth syndrome: A newly identified entity caused by pathogenic variants in platelet-derived growth factor receptor-beta.
Takenouchi T; Okuno H; Kosaki K
Am J Med Genet C Semin Med Genet; 2019 Dec; 181(4):650-657. PubMed ID: 31710779
[TBL] [Abstract][Full Text] [Related]
3. Kosaki overgrowth syndrome due to a novel de novo PDGFRB variant.
Hernández Dorronsoro U; Gawlinski P; Lasa-Aranzasti A; Martínez-Soroa I; Artola Aizalde E; Saez Villaverde R; Aguirre Rodríguez C; Satrustegi Aritziturri M
Clin Genet; 2022 Jan; 101(1):144-145. PubMed ID: 34708400
[No Abstract] [Full Text] [Related]
4. Kosaki overgrowth syndrome: A novel pathogenic variant in PDGFRB and expansion of the phenotype including cerebrovascular complications.
Foster A; Chalot B; Antoniadi T; Schaefer E; Keelagher R; Ryan G; Thomas Q; Philippe C; Bruel AL; Sorlin A; Thauvin-Robinet C; Bardou M; Luu M; Quenardelle V; Wolff V; Woodley J; Vabres P; Lim D; Igbokwe R; Joseph A; Walker H; Jester A; Ellenbogen J; Johnson D; Rooke B; Moss C; Cole T; Faivre L
Clin Genet; 2020 Jul; 98(1):19-31. PubMed ID: 32291752
[TBL] [Abstract][Full Text] [Related]
5. STAT1 modulates tissue wasting or overgrowth downstream from PDGFRβ.
He C; Medley SC; Kim J; Sun C; Kwon HR; Sakashita H; Pincu Y; Yao L; Eppard D; Dai B; Berry WL; Griffin TM; Olson LE
Genes Dev; 2017 Aug; 31(16):1666-1678. PubMed ID: 28924035
[TBL] [Abstract][Full Text] [Related]
6. Segmental overgrowth and aneurysms due to mosaic PDGFRB p.(Tyr562Cys).
Chenbhanich J; Hu Y; Hetts S; Cooke D; Dowd C; Devine P; ; Russell B; Kang SHL; Chang VY; Abla AA; Cornett P; Yeh I; Lee H; Martinez-Agosto JA; Frieden IJ; Shieh JT
Am J Med Genet A; 2021 May; 185(5):1430-1436. PubMed ID: 33683022
[TBL] [Abstract][Full Text] [Related]
7. PDGFRB mutants found in patients with familial infantile myofibromatosis or overgrowth syndrome are oncogenic and sensitive to imatinib.
Arts FA; Chand D; Pecquet C; Velghe AI; Constantinescu S; Hallberg B; Demoulin JB
Oncogene; 2016 Jun; 35(25):3239-48. PubMed ID: 26455322
[TBL] [Abstract][Full Text] [Related]
8. Expansion of the phenotype of Kosaki overgrowth syndrome.
Minatogawa M; Takenouchi T; Tsuyusaki Y; Iwasaki F; Uehara T; Kurosawa K; Kosaki K; Curry CJ
Am J Med Genet A; 2017 Sep; 173(9):2422-2427. PubMed ID: 28639748
[TBL] [Abstract][Full Text] [Related]
9. Constitutive activation of the PI3K-AKT pathway and cardiovascular abnormalities in an individual with Kosaki overgrowth syndrome.
Zarate YA; Boccuto L; Srikanth S; Pauly R; Ocal E; Balmakund T; Hinkle K; Stefans V; Schaefer GB; Collins RT
Am J Med Genet A; 2019 Jun; 179(6):1047-1052. PubMed ID: 30941910
[TBL] [Abstract][Full Text] [Related]
10. Modulation of expressivity in PDGFRB-related infantile myofibromatosis: a role for PTPRG?
Linhares ND; Freire MC; Cardenas RG; Bahia M; Puzenat E; Aubin F; Pena SD
Genet Mol Res; 2014 Aug; 13(3):6287-92. PubMed ID: 25158255
[TBL] [Abstract][Full Text] [Related]
11. A novel de novo PDGFRB variant in a child with severe cerebral malformations, intracerebral calcifications, and infantile myofibromatosis.
Guimier A; Gordon CT; Hully M; Blauwblomme T; Minard-Colin V; Bole-Feysot C; Nitschké P; Oufadem M; Boddaert N; Sarnacki S; Amiel J
Am J Med Genet A; 2019 Jul; 179(7):1304-1309. PubMed ID: 31004414
[TBL] [Abstract][Full Text] [Related]
12. Mutation of the PDGFRB gene as a cause of idiopathic basal ganglia calcification.
Nicolas G; Pottier C; Maltête D; Coutant S; Rovelet-Lecrux A; Legallic S; Rousseau S; Vaschalde Y; Guyant-Maréchal L; Augustin J; Martinaud O; Defebvre L; Krystkowiak P; Pariente J; Clanet M; Labauge P; Ayrignac X; Lefaucheur R; Le Ber I; Frébourg T; Hannequin D; Campion D
Neurology; 2013 Jan; 80(2):181-7. PubMed ID: 23255827
[TBL] [Abstract][Full Text] [Related]
13. Phenotype expansion and development in Kosaki overgrowth syndrome.
Gawliński P; Pelc M; Ciara E; Jhangiani S; Jurkiewicz E; Gambin T; Różdżyńska-Świątkowska A; Dawidziuk M; Coban-Akdemir ZH; Guilbride DL; Muzny D; Lupski JR; Krajewska-Walasek M
Clin Genet; 2018 Apr; 93(4):919-924. PubMed ID: 29226947
[TBL] [Abstract][Full Text] [Related]
14. EED-associated overgrowth in a second male patient.
Cohen AS; Gibson WT
J Hum Genet; 2016 Sep; 61(9):831-4. PubMed ID: 27193220
[TBL] [Abstract][Full Text] [Related]
15. A Point Mutation in PDGFRB Causes Autosomal-Dominant Penttinen Syndrome.
Johnston JJ; Sanchez-Contreras MY; Keppler-Noreuil KM; Sapp J; Crenshaw M; Finch NA; Cormier-Daire V; Rademakers R; Sybert VP; Biesecker LG
Am J Hum Genet; 2015 Sep; 97(3):465-74. PubMed ID: 26279204
[TBL] [Abstract][Full Text] [Related]
16. Progressive cerebral and coronary aneurysms in the original two patients with Kosaki overgrowth syndrome.
Takenouchi T; Kodo K; Yamazaki F; Nakatomi H; Kosaki K
Am J Med Genet A; 2021 Mar; 185(3):999-1003. PubMed ID: 33382209
[TBL] [Abstract][Full Text] [Related]
17. Interstitial 9q22.3 microdeletion: clinical and molecular characterisation of a newly recognised overgrowth syndrome.
Redon R; Baujat G; Sanlaville D; Le Merrer M; Vekemans M; Munnich A; Carter NP; Cormier-Daire V; Colleaux L
Eur J Hum Genet; 2006 Jun; 14(6):759-67. PubMed ID: 16570072
[TBL] [Abstract][Full Text] [Related]
18. Mutations in NSD1 are responsible for Sotos syndrome, but are not a frequent finding in other overgrowth phenotypes.
Türkmen S; Gillessen-Kaesbach G; Meinecke P; Albrecht B; Neumann LM; Hesse V; Palanduz S; Balg S; Majewski F; Fuchs S; Zschieschang P; Greiwe M; Mennicke K; Kreuz FR; Dehmel HJ; Rodeck B; Kunze J; Tinschert S; Mundlos S; Horn D
Eur J Hum Genet; 2003 Nov; 11(11):858-65. PubMed ID: 14571271
[TBL] [Abstract][Full Text] [Related]
19. Growth pattern of Rahman syndrome.
Takenouchi T; Uehara T; Kosaki K; Mizuno S
Am J Med Genet A; 2018 Mar; 176(3):712-714. PubMed ID: 29383847
[TBL] [Abstract][Full Text] [Related]
20. A new overgrowth syndrome is due to mutations in RNF125.
Tenorio J; Mansilla A; Valencia M; Martínez-Glez V; Romanelli V; Arias P; Castrejón N; Poletta F; Guillén-Navarro E; Gordo G; Mansilla E; García-Santiago F; González-Casado I; Vallespín E; Palomares M; Mori MA; Santos-Simarro F; García-Miñaur S; Fernández L; Mena R; Benito-Sanz S; del Pozo Á; Silla JC; Ibañez K; López-Granados E; Martín-Trujillo A; Montaner D; ; Heath KE; Campos-Barros Á; Dopazo J; Nevado J; Monk D; Ruiz-Pérez VL; Lapunzina P
Hum Mutat; 2014 Dec; 35(12):1436-41. PubMed ID: 25196541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
